Literature DB >> 19693528

A myth of ophthalmic beta-blockers therapy.

Weekitt Kittisupamongkol.   

Abstract

Mesh:

Substances:

Year:  2009        PMID: 19693528     DOI: 10.1007/s00417-009-1164-9

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


× No keyword cloud information.
  4 in total

Review 1.  Systemic adverse effects of beta-adrenergic blockers: an evidence-based assessment.

Authors:  Paul J Lama
Journal:  Am J Ophthalmol       Date:  2002-11       Impact factor: 5.258

Review 2.  Beta-blockers: new standard therapy for heart failure.

Authors:  Allison M Pritchett; Margaret M Redfield
Journal:  Mayo Clin Proc       Date:  2002-08       Impact factor: 7.616

3.  The purpose of medical education.

Authors:  G W PICKERING
Journal:  Br Med J       Date:  1956-07-21

4.  Evaluation of risk of falls and orthostatic hypotension in older, long-term topical beta-blocker users.

Authors:  Wishal D Ramdas; Nathalie van der Velde; Tischa J M van der Cammen; Roger C W Wolfs
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-05-19       Impact factor: 3.117

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.